CORCEPT THERAPUETICS RECRUITING STUDIES: • CORT125134-456 (GRADIENT) – Hypercortisolism The purpose of this study was to assess the safety of the combination of relacorilant (CORT125134), a novel glucocorticoid receptor (GR) antagonist, and nab- paclitaxel in participants with solid tumors and to determine the preliminary efficacy of the combination [...]
We are a specialized clinical research company that conducts trials on behalf of our partners in the fields of endocrinology, diabetes, cardiovascular disease, renal disease, and beyond.
PlanIt Research is affiliated with the Endocrine Center of Houston.
CONTACT INFORMATION
10837 Katy Frwy, #200
Houston, TX 77079
713-973-3418
713-973-3415
info@PlanItResearch.com
© Copyright 2023 PlanIt Research | All Rights Reserved